Physician profile
Brian D King
NPI 1104896307
$1,192.10
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $300 · 2021: $652 · 2022: $13.68.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $217.31 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $188.60 | 2019-2021 | |
| Novo Nordisk INC | $100.22 | 2019-2021 | |
| Abbvie INC. | $83.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $83.08 | 2019 | |
| Pfizer INC. | $63.98 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $60.23 | 2020-2021 | |
| Glaxosmithkline, LLC. | $49.96 | 2021 | |
| Abbott Laboratories | $49.79 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.73 | 2021 | |
| Amgen INC. | $35.41 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.24 | 2021 | |
| Dexcom, INC. | $28.54 | 2021 | |
| Ironshore Pharmaceuticals INC. | $23.98 | 2019 | |
| Merck Sharp & Dohme LLC | $22.85 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $21.66 | 2020 | |
| Acadia Pharmaceuticals INC | $17.89 | 2021 | |
| Insulet Corporation | $17.23 | 2021 | |
| Eisai INC. | $15.57 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.82 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.